Literature DB >> 7733359

Heterogeneity in role of endothelium-derived NO in pulmonary arteries and veins of full-term fetal lambs.

Y Gao1, H Zhou, J U Raj.   

Abstract

Endothelium-derived nitric oxide (EDNO) modulates fetal pulmonary vasoactivity. The role of EDNO in regulation of vasomotor tone in fetal pulmonary arteries vs. that in veins is not known. We have investigated the role of EDNO in the responses of pulmonary arteries and veins of full-term fetal lambs. Fourth-generation pulmonary arterial and venous rings were suspended in organ chambers filled with modified Krebs-Ringer bicarbonate solution (95% O2-5% CO2 at 37 degrees C), and their isometric force was measured. N omega-nitro-L-arginine had no effect on the resting tension of pulmonary arteries with endothelium but caused contraction of pulmonary veins with endothelium. The basal level of intracellular guanosine 3',5'-cyclic monophosphate (cGMP) of pulmonary veins with endothelium was higher than that of arteries with endothelium. In pulmonary arteries, bradykinin, but not acetylcholine, induced endothelium-dependent relaxation and an increase in cGMP content. In pulmonary veins, acetylcholine, but not bradykinin, induced endothelium-dependent relaxation and an increase in cGMP content. Agonist-induced maximal relaxation and increases in cGMP content were smaller in pulmonary arteries than in veins. All these endothelium-dependent responses were abolished by N omega-nitro-L-arginine. In tissues without endothelium, nitric oxide induced significantly less relaxation and less increase in cGMP content in pulmonary arteries than in pulmonary veins. All vessels relaxed similarly to 8-bromoguanosine 3',5'-cyclic monophosphate. Our data suggest that the role of EDNO in modulating tone differs between pulmonary arteries and veins in full-term fetal lambs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733359     DOI: 10.1152/ajpheart.1995.268.4.H1586

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Endothelial nitric oxide synthase in hypoxic newborn porcine pulmonary vessels.

Authors:  A A Hislop; D R Springall; H Oliveira; J S Pollock; J M Polak; S G Haworth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

2.  Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery.

Authors:  S Salomone; C L Silva; N Morel; T Godfraind
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

3.  Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near-term fetal lambs.

Authors:  Robert C Dukarm; Robin H Steinhorn; James A Russell; Satyan Lakshminrusimha; Daniel Swartz; James J Cummings
Journal:  J Appl Physiol (1985)       Date:  2005-08-25

4.  Paracrine role of soluble guanylate cyclase and type III nitric oxide synthase in ovine fetal pulmonary circulation: a double labeling immunohistochemical study.

Authors:  Ching Tzao; Peter A Nickerson; James A Russell; Bernice K Noble; Robin H Steinhorn
Journal:  Histochem Cell Biol       Date:  2003-01-21       Impact factor: 4.304

5.  Long-term effects of prenatal hypoxia on endothelium-dependent relaxation responses in pulmonary arteries of adult sheep.

Authors:  Jie Liu; Yuansheng Gao; Sewite Negash; Lawrence D Longo; J Usha Raj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-09       Impact factor: 5.464

6.  Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase.

Authors:  Yuansheng Gao; Ada D Portugal; Jie Liu; Sewite Negash; Weilin Zhou; Jia Tian; Ruolan Xiang; Lawrence D Longo; J Usha Raj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-29       Impact factor: 5.464

Review 7.  Modulation of pulmonary vasomotor tone in the fetus and neonate.

Authors:  N S Ghanayem; J B Gordon
Journal:  Respir Res       Date:  2001-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.